Annual SG&A
$0.00$152.95M-100.00%
Summary
- Current Value
- As of today, DVAX annual SG&A is $0.00, down -100.00% on
- Historical Performance
- DVAX annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- DVAX annual SG&A is currently -100.00% below its historical high of $152.95M set on
- 3-Year Low Comparison
- DVAX annual SG&A vs 3-year low value is unknown
- Sector Comparison
- DVAX annual SG&A is higher than 39.34% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$3.84B | -2356.2% | -3060.3% | -4794.4% | -10000.0% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| Annual Operating Expenses | $231.92M | +7.3% | +77.8% | +80.0% | +1434.4% | |
| Annual Operating Profit | -$4.12M | +87.9% | -103.1% | +96.5% | +72.7% | |
| Annual D&A | $8.05M | +10.7% | +14.8% | -62.6% | +183.8% | |
| Annual Revenue | $277.25M | +19.4% | -36.6% | +687.2% | +587.6% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $152.95M | -100.0% | |
| 5Y | $152.95M | -100.0% | |
| All | $152.95M | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of DVAX?
As of today, DVAX annual SG&A is $0.00
What is 1-year change in DVAX annual SG&A?
DVAX annual SG&A is down -100.00% year-over-year
What is 3-year change in DVAX annual SG&A?
DVAX annual SG&A is down -100.00% over the past 3 years
How far is DVAX annual SG&A from its all-time high?
DVAX annual SG&A is currently -100.00% below its historical high of $152.95M set on December 31, 2023
How does DVAX annual SG&A rank versus sector peers?
DVAX annual SG&A is higher than 39.34% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly SG&A
$0.00$50.36M-100.00%
Summary
- Current Value
- As of today, DVAX quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- DVAX quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- DVAX quarterly SG&A is currently -100.00% below its historical high of $50.36M set on
- 3-Year Low Comparison
- DVAX quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- DVAX quarterly SG&A is higher than 45.58% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$3.84B | -2200.4% | -2356.2% | -3060.3% | -4794.4% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| Quarterly Operating Expenses | $59.20M | -11.6% | +3.0% | +32.8% | +101.8% | |
| Quarterly Operating Profit | $21.27M | +47.4% | +111.0% | -65.6% | +206.6% | |
| Quarterly D&A | $2.09M | +2.7% | +1.9% | +40.5% | +19.8% | |
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $50.36M | -100.0% | |
| 3Y | $50.36M | -100.0% | |
| 5Y | $50.36M | -100.0% | |
| All | $50.36M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of DVAX?
As of today, DVAX quarterly SG&A is $0.00
What is DVAX quarterly SG&A most recent change?
DVAX quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in DVAX quarterly SG&A?
DVAX quarterly SG&A is down -100.00% year-over-year
How far is DVAX quarterly SG&A from its all-time high?
DVAX quarterly SG&A is currently -100.00% below its historical high of $50.36M set on June 30, 2025
How does DVAX quarterly SG&A rank versus sector peers?
DVAX quarterly SG&A is higher than 45.58% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM SG&A
-$3.84B$43.40M-1.14%
Summary
- Current Value
- As of today, DVAX TTM SG&A is -$3.84B, down -1.14% on
- Historical Performance
- DVAX TTM SG&A is down -2356.19% year-over-year, and down -3060.28% over the past 3 years
- All-Time High Comparison
- DVAX TTM SG&A is currently -5028.00% below its historical high of -$74.83M set on an earlier date
- 3-Year Low Comparison
- DVAX TTM SG&A is +7.68% above its 3-year low of -$4.16B reached on an earlier date
- Sector Comparison
- DVAX TTM SG&A is higher than 13.12% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$3.84B | -2200.4% | -2356.2% | -3060.3% | -4794.4% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| TTM Operating Profit | $10.44M | +1489.9% | +240.2% | -96.5% | +111.9% | |
| TTM D&A | $8.24M | +0.5% | +3.8% | +18.8% | -29.1% | |
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.68B | N/A | -4.2% |
| 3Y | -$3.68B | N/A | -4.2% |
| 5Y | -$3.68B | N/A | -4.2% |
| All | -$74.83M | N/A | -5028.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.84B | N/A | at low |
| 3Y | -$4.16B | N/A | +7.7% |
| 5Y | -$5.19B | N/A | +26.1% |
| All | -$5.19B | N/A | +26.1% |
TTM SG&A History
FAQ
What is the current TTM SG&A of DVAX?
As of today, DVAX TTM SG&A is -$3.84B
What is DVAX TTM SG&A most recent change?
DVAX TTM SG&A was down -1.14% on September 30, 2025
What is 1-year change in DVAX TTM SG&A?
DVAX TTM SG&A is down -2356.19% year-over-year
How does DVAX TTM SG&A rank versus sector peers?
DVAX TTM SG&A is higher than 13.12% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax